Callan Capital, LLC Infinity Pharmaceuticals, Inc. Transaction History

Callan Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.46 - $1.21 $72,910 - $191,785	158,500 New	158,500 $88,000
Q1 2022 May 10, 2022	SELL	$0.85 - $2.4 $124,270 - $350,880	-146,200 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$1.52 - $3.82 $37,088 - $93,208	24,400 Added 20.03%	146,200 $500,000
Q2 2021 Aug 10, 2021	BUY	$2.66 - $3.47 $323,988 - $422,646	121,800 New	121,800 $364,000
Q1 2021 May 10, 2021	SELL	$1.98 - $5.36 $144,936 - $392,352	-73,200 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$1.05 - $2.77 $76,860 - $202,764	73,200 New	73,200 $155,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Callan Capital, LLC with notifications on news.